{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:11:51Z","timestamp":1784761911189,"version":"3.55.0"},"reference-count":14,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","award":["ECDC\/2021\/019"],"award-info":[{"award-number":["ECDC\/2021\/019"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We estimated XBB.1.5 vaccine effectiveness (VE) against symptomatic SARS\u2010CoV\u20102 infection among adults aged \u2265\u200965\u2009years during the 2023\/2024 JN.1 lineage\u2010predominant period in a European multi\u2010country test\u2010negative case\u2013control study at primary care level. We estimated VE adjusted by study site, age, sex, chronic conditions and onset date. We included 220 cases and 1733 controls. The VE was 48% (95% CI: 12\u201371), 23% (95% CI: \u221211\u201348) and 5% (95% CI: \u221292\u201356) among those with symptom onset 1\u20135, 6\u201311, and \u2265\u200912\u2009weeks after vaccination, respectively. XBB.1.5 vaccine provided short and moderate protection against JN.1 symptomatic infection.<\/jats:p>","DOI":"10.1111\/irv.70009","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T07:54:32Z","timestamp":1731311672000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS\u2010CoV\u20102 Infection in Older Adults During the JN.1 Lineage\u2010Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023\u20131 March 2024"],"prefix":"10.1111","volume":"18","author":[{"given":"Lore","family":"Merdrignac","sequence":"first","affiliation":[{"name":"Epidemiology Department Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Laniece\u00a0Delaunay","sequence":"additional","affiliation":[{"name":"Epidemiology Department Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Verdasca","sequence":"additional","affiliation":[{"name":"National Reference Laboratory for Influenza Virus and Other Respiratory Viruses, Infectious Disease Department National Institute of Health Doutor Ricardo Jorge  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Vega\u2010Piris","sequence":"additional","affiliation":[{"name":"National Centre of Epidemiology, CIBERESP Carlos III Health Institute  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"O'Donnell","sequence":"additional","affiliation":[{"name":"Health Service Executive\u2010Health Protection Surveillance Centre  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"S\u00e8ve","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d'Epid\u00e9miologie et de Sant\u00e9 Publique, IPLESP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camino","family":"Trobajo\u2010Sanmart\u00edn","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra \u2010 IdiSNA \u2013 CIBERESP  Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Buda","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology Robert Koch Institute  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte","family":"Hooiveld","sequence":"additional","affiliation":[{"name":"Nivel  Utrecht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00a0Paula","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Epidemiology Department National Institute of Health Doutor Ricardo Jorge  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerg\u0151","family":"T\u00fari","sequence":"additional","affiliation":[{"name":"National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Latorre\u2010Margalef","sequence":"additional","affiliation":[{"name":"Department of microbiology Public Health Agency of Sweden  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Mlinari\u0107","sequence":"additional","affiliation":[{"name":"Division for Epidemiology of Communicable Diseases Croatian Institute of Public Health  Zagreb Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Lazar","sequence":"additional","affiliation":[{"name":"National Influenza Centre Cantacuzino National Military Medical Institute for Research and Development  Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Maurel","sequence":"additional","affiliation":[{"name":"Epidemiology Department Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Castrillejo","sequence":"additional","affiliation":[{"name":"Servicio de Vigilancia Epidemiol\u00f3gica, Direcci\u00f3n General de Salud P\u00fablica Consejer\u00eda de Pol\u00edticas Sociales y Salud P\u00fablica  Melilla Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Bennett","sequence":"additional","affiliation":[{"name":"National Virus Reference Laboratory University College Dublin  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie\u2010Anne","family":"Rameix\u2010Welti","sequence":"additional","affiliation":[{"name":"Centre National de R\u00e9f\u00e9rence Virus des Infections Respiratoire (CNR VIR) Institut Pasteur Universit\u00e9 Paris Cit\u00e9  Paris France"},{"name":"Molecular Mechanisms of Multiplication of Pneumovirus Unit, UMR 1173 (2I) Institut Pasteur, Universit\u00e9 Paris\u2010Saclay, Universit\u00e9 de Versailles St. Quentin, INSERM, Universit\u00e9 Paris Cit\u00e9  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Mart\u00ednez\u2010Baz","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra \u2010 IdiSNA \u2013 CIBERESP  Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"D\u00fcrrwald","sequence":"additional","affiliation":[{"name":"National Reference Centre for Influenza Robert Koch Institute  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Meijer","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment Centre for Infectious Diseases Control  Bilthoven the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryse","family":"Melo","sequence":"additional","affiliation":[{"name":"National Reference Laboratory for Influenza Virus and Other Respiratory Viruses, Infectious Disease Department National Institute of Health Doutor Ricardo Jorge  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Oroszi","sequence":"additional","affiliation":[{"name":"National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove\u00a0Samuelsson","family":"Hagey","sequence":"additional","affiliation":[{"name":"Department of microbiology Public Health Agency of Sweden  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Kure\u010di\u0107\u00a0Filipovi\u0107","sequence":"additional","affiliation":[{"name":"Division for Epidemiology of Communicable Diseases Croatian Institute of Public Health  Zagreb Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederika","family":"Dijkstra","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment Centre for Infectious Diseases Control  Bilthoven the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Gomez","sequence":"additional","affiliation":[{"name":"Epidemiology Department National Institute of Health Doutor Ricardo Jorge  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bacci","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation Section European Centre for Disease Prevention and Control  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Kaczmarek","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation Section European Centre for Disease Prevention and Control  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Kissling","sequence":"additional","affiliation":[{"name":"Epidemiology Department Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the VEBIS Primary Care Vaccine Effectiveness Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,10]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.21105\/joss.03773"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00744-2"},{"key":"e_1_2_11_4_1","unstructured":"European Centre for Disease Prevention and Control \u201cInterim COVID\u201019 Vaccination Coverage in the EU\/EEA During the 2023\u201324 Season Campaigns [Internet] \u201d (2024) https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/interim\u2010vaccine\u2010overage\u2010eu\u2010eea\u20102023\u201024.pdf."},{"key":"e_1_2_11_5_1","unstructured":"European Centre for Disease Prevention and Control \u201cCore Protocol for ECDC Studies of Vaccine Effectiveness Against Symptomatic Laboratory\u2010Confirmed Influenza or SARS\u2010CoV\u20102 Infection at Primary Care Level: Version 1.0 September 2023 [Internet] \u201d LU: Publications Office (2023) https:\/\/doi.org\/10.2900\/25966."},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2024.29.13.2300403"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"e_1_2_11_9_1","doi-asserted-by":"crossref","unstructured":"A. R.Caffrey H. J.Appaneal V. V.Lopes et\u00a0al. \u201cEffectiveness of BNT162b2 XBB Vaccine in the US Veterans Affairs Healthcare System [Internet] \u201d (2024) https:\/\/doi.org\/10.1101\/2024.04.05.24305063.","DOI":"10.1101\/2024.04.05.24305063"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7304a2"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.05.067"},{"key":"e_1_2_11_12_1","unstructured":"World Health Organization \u201cUpdated Risk Evaluation of JN.1 15 April 2024 [Internet] \u201d World Health Organization (2024) https:\/\/www.who.int\/docs\/default\u2010source\/coronaviruse\/15042024_jn1_ure.pdf?sfvrsn=8bd19a5c_7."},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.28.24305030"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2024.29.10.2400109"},{"key":"e_1_2_11_15_1","unstructured":"World Health Organization (WHO) \u201cStatement on the Antigen Composition of COVID\u201019 Vaccines [Internet] \u201d (2024) https:\/\/www.who.int\/docs\/default\u2010source\/coronaviruse\/tag\u2010co\u2010vac\u2010annex_26042024.pdf?sfvrsn=7396b6b8_3."}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:43:44Z","timestamp":1732610624000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.70009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1111\/irv.70009"],"URL":"https:\/\/doi.org\/10.1111\/irv.70009","archive":["Portico"],"relation":{},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-06-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70009"}}